Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study. (Record no. 20166016)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01631 a2200409 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250516002243.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201102s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1477-0970 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1177/1352458510378127 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Comi, G |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20110215 |
245 00 - TITLE STATEMENT | |
Title | Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Multiple sclerosis (Houndmills, Basingstoke, England) |
Date of publication, distribution, etc. | Nov 2010 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1360-6 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Administration, Oral |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Brain |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Disability Evaluation |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Double-Blind Method |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Immunologic Factors |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Magnetic Resonance Imaging |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Multiple Sclerosis, Relapsing-Remitting |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Quinolones |
General subdivision | administration & dosage |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Abramsky, O |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Arbizu, T |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Boyko, A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Gold, R |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Havrdová, E |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Komoly, S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Selmaj, K |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Sharrack, B |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Filippi, M |
773 0# - HOST ITEM ENTRY | |
Title | Multiple sclerosis (Houndmills, Basingstoke, England) |
Related parts | vol. 16 |
-- | no. 11 |
-- | p. 1360-6 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1177/1352458510378127">https://doi.org/10.1177/1352458510378127</a> |
Public note | Available from publisher's website |
No items available.